Shivaram Avula graduated from The Tamil Nadu Dr MGR Medical University, India in 1995. He obtained his postgraduate Paediatric degree (MRCPCH, London) in 2001 and Radiology degree (FRCR, London) in 2005. He completed his paediatric radiology and neuroradiology fellowships at Alder Hey Children’s Hospital, Liverpool and Hospital for Sick Children, Toronto. He was appointed as a Consultant Radiologist at Alder Hey in 2009. Shivaram has a special interest in paediatric neuroimaging, and in particular, imaging of paediatric brain tumours. He is the lead radiologist for the Neuro-oncology team at Alder Hey. Shivaram has been the lead radiologist in developing the intraoperative MRI service for brain tumour surgery and has published and presented extensively in this area.
Shivaram is the Current Chair of the International Society of Paediatric Oncology–Europe (SIOP-E BTG) Brain Tumour Imaging group (2013 onwards). He is the imaging representative for the SIOP-E Low grade glioma group, he is the lead radiologist for the upcoming Phase III, randomised, international multicentre trial for children and adolescents with low-grade glioma (LOGGIC). As a member of the UK Children’s Cancer and Leukaemia Group (CCLG), he is actively involved in coordinating and participating in the central radiology review panel for the UK paediatric neuro-oncology studies. He is one of the board members on the Posterior fossa society, an international scientific group working on Postoperative cerebellar mutism.
Shivaram has a research interest in Advanced MRI for brain tumours. He is an honorary clinical associate professor at the Faculty of Health and Life Sciences at the University of Liverpool. He is the chief investigator for MR Bubbles, a novel study evaluating microbubble contrast perfusion in an MRI setting. He is working in collaboration with mathematicians on postoperative cerebellar mutism and has published a new hypothesis on its pathophysiology. This work has been incorporated into the largest European cerebellar mutism study. He is also a collaborator on a multicentre study evaluating imaging biomarkers in medulloblastoma subtypes.